PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 126 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,884 | -26.2% | 1,858,000 | -0.9% | 0.02% | -25.9% |
Q2 2023 | $6,614 | +14.2% | 1,874,123 | -0.0% | 0.03% | +8.0% |
Q1 2023 | $5,792 | -24.5% | 1,874,859 | +3.4% | 0.02% | -34.2% |
Q4 2022 | $7,667 | -99.8% | 1,813,040 | -1.4% | 0.04% | +58.3% |
Q3 2022 | $4,354,000 | -15.5% | 1,838,942 | +1.7% | 0.02% | -7.7% |
Q2 2022 | $5,154,000 | +5.9% | 1,808,828 | +6.9% | 0.03% | +30.0% |
Q1 2022 | $4,869,000 | -8.2% | 1,691,899 | -3.1% | 0.02% | 0.0% |
Q4 2021 | $5,305,000 | -41.7% | 1,746,281 | +34.4% | 0.02% | -42.9% |
Q3 2021 | $9,106,000 | -19.2% | 1,299,547 | +5.9% | 0.04% | -16.7% |
Q2 2021 | $11,270,000 | -4.6% | 1,227,479 | +1.0% | 0.04% | -8.7% |
Q1 2021 | $11,814,000 | +2.5% | 1,215,477 | +8.2% | 0.05% | +2.2% |
Q4 2020 | $11,527,000 | -15.1% | 1,123,532 | -16.6% | 0.04% | -21.1% |
Q3 2020 | $13,582,000 | +2.8% | 1,346,617 | +6.3% | 0.06% | 0.0% |
Q2 2020 | $13,211,000 | +78.8% | 1,266,931 | +44.7% | 0.06% | +35.7% |
Q1 2020 | $7,388,000 | +0.6% | 875,265 | +4.3% | 0.04% | +27.3% |
Q4 2019 | $7,344,000 | +78.5% | 839,122 | +119.5% | 0.03% | +83.3% |
Q3 2019 | $4,114,000 | +27.1% | 382,201 | +50.1% | 0.02% | +12.5% |
Q2 2019 | $3,236,000 | +1718.0% | 254,714 | +5456.6% | 0.02% | +1500.0% |
Q1 2019 | $178,000 | – | 4,584 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
TOBAM | 318,384 | $23,994,000 | 0.94% |
Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |